Direkt zum Inhalt
Merck

F2145

Sigma-Aldrich

Monoclonal Anti-Factor V antibody produced in mouse

clone HV-1, purified immunoglobulin, buffered aqueous solution

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise

Größe auswählen

100 μL
CHF 438.00

CHF 438.00


Voraussichtliches Versanddatum17. Mai 2025


Bulk-Bestellung anfordern

Größe auswählen

Ansicht ändern
100 μL
CHF 438.00

About This Item

MDL-Nummer:
UNSPSC-Code:
12352203
NACRES:
NA.43

CHF 438.00


Voraussichtliches Versanddatum17. Mai 2025


Bulk-Bestellung anfordern

Antikörperform

purified immunoglobulin

Qualitätsniveau

Antikörper-Produkttyp

primary antibodies

Klon

HV-1, monoclonal

Form

buffered aqueous solution

Speziesreaktivität

human

Methode(n)

ELISA: suitable
dot blot: suitable
neutralization: suitable

Isotyp

IgG1

Versandbedingung

dry ice

Lagertemp.

−20°C

Posttranslationale Modifikation Target

unmodified

Angaben zum Gen

human ... F5(2153)

Verwandte Kategorien

Allgemeine Beschreibung

Monoclonal Anti-Factor V (mouse IgG1 isotype) is derived from the HV-1 hybridoma, produced by the fusion of mouse myeloma Sp2/0-Ag14 cells and splenocytes from BALB/c mouse immunized with Factor V, purified from human plasma. Blood coagulation factor V, also known as, proaccelerin or labile factor. The activated factor V (factor Va) is a calcium dependent heterodimer composed of heavy chain (~105 kDa) and light chain (~73 kDa).

Spezifität

The antibody inhibits the activity of Factor V as measured by the prothrombin time (PT) assay.

Immunogen

Factor V from pooled normal human plasma

Anwendung

Monoclonal Anti-Factor V antibody produced in mouse has been used in dot blot and enzyme linked immunosorbent assay (ELISA).

Biochem./physiol. Wirkung

Blood coagulation factor V is an essential component of the prothrombinase complex that catalyzes the rapid conversion of prothrombin to thrombin and is involved in intrinsic and extrinsic coagulation pathways. About 20% of blood factor V is contained within platelets. Factor V circulates in the plasma as a single chain glycoprotein with little or no intrinsic procoagulant activity. It is activated through limited proteolysis by thrombin, factor Xa, or the factor V activator from Russell′s viper venom (RW-V). Activated protein C (APC) with its cofactor protein S, inactivates factors Va and VIIIa to provide a major natural anticoagulant system. APC resistance known as factor V Leiden (FV Leiden) is a common hereditary thrombophilia Factor V mutation, caused by arginine substitution into glutamine at position 506 (R506Q).

Physikalische Form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide as a preservative.

Haftungsausschluss

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Sie haben nicht das passende Produkt gefunden?  

Probieren Sie unser Produkt-Auswahlhilfe. aus.

Lagerklassenschlüssel

10 - Combustible liquids

WGK

WGK 2

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Overview of the coagulation system
Palta S, et al.
Indian journal of anaesthesia, 58(5), 515-515 (2014)
Platelet factor V to the rescue
Camire RM, et al.
Blood, 115(4), 753-754 (2010)
Factor V Leiden and Inflammation
Perez-Pujol S, et al.
Thrombosis, 2012 (2012)
Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation
Bos MHA and Camire RM
Journal of coagulation disorders., 2(2), 19-19 (2010)

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.